阿仑磷酸钠联合金天格治疗糖皮质激素性骨质疏松的临床观察Clinical Observation of Alendronate Combined with Jintiange in Treatment of Glucocorticoid-Induced Osteoporosis
罗群,蔡静月,郑小清,刘华珍,王小平,张华辉,蔡德
LUO Qun,CAI Jingyue,ZHENG Xiaoqing,LIU Huazhen,WANG Xiaoping,ZHANG Huahui,CAI De
摘要(Abstract)：
目的探讨阿仑磷酸钠联合金天格胶囊治疗糖皮质激素性骨质疏松患者的临床疗效。方法采用随机对照试验设计,对46例糖皮质激素性骨质疏松患者分组,治疗组(n=23)使用阿仑磷酸钠片联合金天格胶囊,同时服用碳酸钙;对照组(n=23)给予骨化三醇和碳酸钙,连续治疗6个月,记录2组患者治疗前后的临床疗效、骨密度变化及碱性磷酸酶等数据。结果治疗6个月后,治疗组有效率高于对照组(P>0.05),治疗组患者的骨密度值增加明显(P<0.05),碱性磷酸酶下降显著(P<0.000 1)。结论阿仑磷酸钠联合金天格治疗糖皮质激素性骨质疏松的效果较好,能够有效改善临床症状,明显增加骨密度,安全性好,但长期疗效有待进一步研究。
OBJECTIVE To explore the clinical effect of alendronate combined with Jintiange capsules in treatment of patients with glucocorticoid-induced osteoporosis. METHODS Forty-six glucocorticoid-induced osteoporosis patients were randomly divided into 2 groups. During 6 month's therapy,patients of the treatment group( n = 23) taken alendronate tablets,Jintiange capsules and calcium carbonate,while patients of the control group( n = 23) taken calcitriol and calcium carbonate. The clinical effects,bone mineral density and alkaline phosphatase were compared before and after the treatment. RESULTS After 6 month,compared with the control group,the clinical effects of patients in the treatment group was higher( P > 0. 05),the bone mineral density and alkaline phosphatase were remarkable increased and decreased,respectively( P < 0. 05). CONCLUSION Alendronate combined with Jintiange capsules can effectively improve bone mineral density and relieve clinical symptoms,and it had good security in patients with glucocorticoid-induced osteoporosis,but it still requires further clinical study.
关键词(KeyWords)：
阿仑膦酸钠;金天格;糖皮质激素性骨质疏松症;临床疗效
alendronate;Jintiange;glucocorticoid-induced osteoporosis;clinical effect
基金项目(Foundation):
作者(Author):
罗群,蔡静月,郑小清,刘华珍,王小平,张华辉,蔡德
LUO Qun,CAI Jingyue,ZHENG Xiaoqing,LIU Huazhen,WANG Xiaoping,ZHANG Huahui,CAI De
参考文献(References)：
- [1]陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008,835-840.
- [2]Albrecht W,Isenegger P,Buergi E,et al.Glucocorticosteroid-induced spinal osteoporosis:scientific update on pathophysiology and treatment[J].Eur Spine,2006,15:1035-1049.
- [3]Suzuki Y,Sato S.Secondary osteoporosis UPDATE.Clinical significance of glucocorticoid-induced osteoporosis[J].Clin Calcium,2010,20(5):645-653.
- [4]Gera C,Vij AS.Glucocorticoid-induced osteoporosis:unawareness or negligence in India[J].Int J Rheum Dis,2009,12(3):230-233.
- [5]GONG Jianping,ZHAN Yexiang.Analysis of the Utilization of Glucocorticoids[J].Friend of Chemical Industry,2012,(28):2-3.
- [6]Kenneth G,Saag K.Glucocorticoid-induced osteoporosis[J].Endocrinol Metab Clin N An,2003,32:135-157.
- [7]Chiodini I,Torlontano M,Carnevale V,et al.Skeletal involvement in adult patients with endogenous hypercortisolism[J].Endocrinol Invest,2008,31:267-276.
- [8]De Nijs N,Jacobs W,Lems F,et al.Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis[J].N Engl J Med,2006,355:675-684.
- [9]Baron R.Osteoporosis in 2011:Osteoporosis therapy-dawn of the post-bisphosphonate era[J].Nat Rev Endocrinol,2011,8:76-78.
- [10]Stoch A,Saag K,Greenwald M,et al.Once-weekly oral alendronate 70mg in patients with glucocorticoid-induced bone loss:a12-month randomized,placebo-controlled clinical trial[J].Rheumatol,2009,36:1705-1714.
- [11]王玉清,韩大为.人工虎骨粉的药理作用研究进展[J].中医正骨,2006,18(11):70-71.
- [12]赵冀伟.金天格胶囊治疗骨质疏松性骨折50例临床研究[J].中国骨质疏松杂志,2012,18(1):63-65.
- [13]廖有乔,杨坤,何明武,等.辅以金天格胶囊治疗老年骨质疏松性粗隆间骨折的疗效观察[J].中国骨质疏松杂志,2011,17(6):523-525.
- [14]吴官保,徐无忌,杨彬.金天格胶囊对骨质疏松性肱骨外科颈骨折愈合的影响[J].中国骨质疏松杂志,2011,17(1):64-66.